The Royal College of Radiologists (RCR) has awarded Daniel J. Indelicato, MD, Professor and Associate Vice Chair of the University of Florida Department of Radiation Oncology, its prestigious Honorary Fellowship. Dr. Indelicato accepted the Fellowship diploma in person at the Royal College, London, on March 24, 2023.
The RCR, established in 1975, awards Honorary Fellowships to outstanding individuals who have made notable contributions to, or promoted the interests of, clinical radiology or clinical oncology. It is the highest honor that can be awarded to an individual who is not a Fellow of the College.
“This achievement would not have been possible without the expertise and contributions of our UF Health Proton Therapy Institute and UF Radiation Oncology teams,” said Dr. Indelicato (shown right, at the RCR in London). “I am extremely privileged to receive this recognition and grateful for their support.”
Dr. Indelicato holds the William and Joan Mendenhall Endowed Professorship of Pediatric Radiotherapy and directs the University of Florida pediatric radiotherapy program at the institute (UFHPTI), in Jacksonville, Florida.
“Between 2008 and 2020, Dr. Indelicato was responsible for the radiotherapeutic management of several hundred UK children who were referred via the NHS Proton Overseas Programme,” said RCR President, Dr. Katharine Halliday, during the March 24th ceremony. “Dr Indelicato collaborated closely with referring clinical teams in the UK to develop seamless transfer of potentially ill young patients and their families across the Atlantic to receive technically complex radiotherapy. The exemplary care from the team in Florida was underpinned by an unwavering commitment by Dr Indelicato. He has been an inspirational teacher, benefiting the team with his vast experience in pediatric radiation oncology.
“The team at the University of Florida has invested huge resource into research with the aim of collecting detailed clinical outcome data, and Dr Indelicato continues to monitor outcomes for the patients from the UK,” she continued. “He has authored and co-authored over 175 peer reviewed papers, many of which are collaborations between the University of Florida and UK teams. He is a valuable contributor to the UK Children’s Cancer and Leukaemia Radiotherapy Group. Dr Indelicato is universally adored by his patients and their families, some of whom still return to Florida for their follow up with ‘Dr Danny’.”
Dr. Indelicato’s research has defined the role of proton therapy in treating children and young adults with brain tumors and sarcoma. He and his team at UF have advanced organ-specific radiation tolerance models for pediatric patients, contributing to improved outcomes worldwide.